Summit Therapeutics SMMT
NASDAQ SMMT
$17.08 -0.75 (-4.21%)
As of: Nov 11, 2026 · 11:41 AM EST

Summit Therapeutics (SMMT) Deferred Taxes (2019 - 2020)

Updated

Summit Therapeutics (SMMT) reported Deferred Taxes of -$99,000 for Q4 2020, compared with $120,000 a year earlier.

Analysis

Summit Therapeutics (SMMT) Deferred Taxes (2019 - 2020) Analysis & Trends

For FY2018, Summit Therapeutics posted Deferred Taxes of -$1.91 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -665.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -1.79 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -56.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -612.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -120.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 202.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -860.00 Mn
10 Summit Therapeutics 14.26 Bn 11.63 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -99,000.00
Dec 31, 2019 120,000.00
API Access

Summit Therapeutics Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=SMMT&period=max&api_key=YOUR_API_KEY